
Results
2
2 companies
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.53
7D
3.3%
1Y
-23.8%
AcrobiosystemsLtd
Market Cap: CN¥8.1b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥48.35
7D
-4.4%
1Y
-6.4%